Drug lipophilicity is a core property that contributes to drug solubility, permeability, metabolic disposition, and other key properties. Take a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.
This poster demonstrates the application of in vitro flux assays to nanoparticles, with data on how thein vitro permeability apparatus can be utilized to characterize the membrane flux performance of an API formulated as a nanosuspension.
As patients take an increasingly active role in their own health and become more empowered, it is essential to promote better adherence, improve medical benefits, and bolster market perception. Explore the evolving technologies enabling this shift toward improved quality of life and the potential of nanotechnology to aid this transition.
Discover how Nanoform’s revolutionary and environmentally sustainable nanoparticle technologies, coupled with its innovative formulation approaches, can not only address drug solubility issues but also add value for patients in novel drug delivery applications.
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
